{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-021392","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.672281+00:00","generated_at":"2026-05-16T22:11:51.579727+00:00","sec_items":["7.01","2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"medium","headline":"Elite Pharma to release Q2 FY2026 results Nov 14; conference call Nov 17","bullets":["Q2 FY2026 financial results (ended Sep 30, 2025) to be released on Friday, November 14, 2025.","Management conference call set for Monday, November 17, 2025, at 11:30 AM EST.","Dial-in numbers: 1-800-346-7359 (domestic), 1-973-528-0008 (international); conference ID 98840.","Stockholder questions accepted via email (dianne@elitepharma.com) by deadlines listed in release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-021392","json":"https://secwatch.observer/filing/0001493152-25-021392.json","markdown":"https://secwatch.observer/filing/0001493152-25-021392.md","text":"https://secwatch.observer/filing/0001493152-25-021392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/0001493152-25-021392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:11:51.579727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}